Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma | Greenville, SC, United States | Makes it | No problems foundAug 1, 2025 · 18 inspections, 1 with FDA action |
Recalls
- Jul 29, 2021 · Class II · PAI Holdings, LLC. dba Pharmaceutical Associates Inc
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Lots: Lot: C9BC Exp. 31OCT2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ethosuximide: every company that makes it
- Form
- solution, oral
- Strength
- 250 mg per 5 mL
- Approval
- ANDA ANDA040253
- On the market since
- Nov 22, 2000
- Package NDCs
0121-0670-16- Official label
- DailyMed (National Library of Medicine), updated Oct 17, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?